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Proteins constitute an important part of cell machinery that performs a plethora of functions.
Here, we studied three different protein systems, the practical result of which is to indicate that
proteins can be studied from different perspectives. We used multiple biophysical and
biochemical approaches to probe protein-protein and protein-polymer interactions. Chapters 3
and 4 focus on structural and thermodynamics aspects of protein-protein interactions, while
chapter 5 has a more biochemical appeal in characterizing protein-polymer conjugates.
Through NMR studies, we identified the binding interface of integrin β3 onto the Src SH3
domain. We further tested the influence of tyrosine phosphorylation, a characteristic feature of
activated β3 receptor. Additionally, we provide key insights into the role of phosphorylated β3
and its interaction with Src kinase. Overall, the results from these studies contribute to our
current understanding of Src mediated integrin signaling.
Next, we performed a detailed study on calmodulin (CaM), which forms a globular compact
structure upon binding with smooth muscle myosin light chain kinase (smMLCK). We
modified CaM at its N- and C-termini and used the formation of disulfide bond to create an
artificial circular protein. We studied the effect of this topological constraint on internal
dynamics and molecular recognition. Using NMR relaxation techniques, we observed a slight
reduction in the backbone mobility of the central loop and the C-lobe residues. ITC studies of
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CaM with smMLCK revealed that in contrast to its linear counterpart, binding of cyclic CaM has
a favorable change in entropy of binding (ΔS). Intriguingly, the overall Gibbs free energy of
binding remained nearly constant between the two constructs.
Lastly, we site-specifically linked enzymes to bi-functionalized polymeric scaffolds via
bioorthogonal chemistry. We present a method to prepare functionally active Cel48F-cutinase
engineered protein that can be site specifically linked with phosphonate-functionalized polymers.
In addition, we also present the preliminary results of Cel48F-SNAP that can covalently bind to
benzylguanine derivatives. Our long-term goal is to prepare supramolecular protein-polymeric
assembly that can mimic the natural cellulosome in catalyzing the conversion of cellulose to
glucose, an important biochemical reaction in biofuel industry.
Collectively, these studies used multifarious approaches to explore diverse protein-protein and
protein-polymer interactions.
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Chapter 1. Introduction
The central dogma of molecular biology explains the flow of genetic information from DNA to
RNA, which is further translated to make functional molecules, called proteins. Proteins
constitute an important part of cell machinery that performs a magnificently diverse set of
functions. They serve as structural components, are involved in cell signaling, catalyze reactions,
acts as storage and transport molecules, and are therefore extensively studied. The interest in
studying a specific protein arises from its participation in biologically relevant process. The
biological properties a protein exhibits are conferred by its physical interaction with other
molecules. These molecules, referred to as ligands can vary from being an ion, a small molecule
or a macromolecule.
In this thesis, each chapter details about a specific protein, the practical result of these diverse
choices of proteins is to indicate that the proteins can be studied from one or more different
perspectives.

1.1 Synopsis
The following subsections describe the broad focus of each chapter.
1.1.1

Protein-protein interactions

Proteins are inherently meant to work cohesively with other proteins or act in conjunction with
other scaffolds to achieve their functionalities. A detailed understanding of protein-protein
interactions is fundamental for a thorough evaluation of biological processes such as blood
coagulation, inflammatory response, and also for certain diseased states like cancer. By
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integrating structural characterization with emphasis on molecular details, we can precisely
delineate the mechanisms and the forces governing protein-protein interactions.
1.1.2

Effect of structural modifications on protein interactions

Proteins are dynamic molecules, and because of observed flexibility they can adopt different
conformations in apo and bound forms. The conformational change can influence the pathway in
which the protein would be involved and can further regulate its function. Of the many methods,
introduction of disulfide linkage has been proven successful to emulate the well-defined
conformation of proteins or to lock them in their active conformations. Though considerable
research has been done in studying disulfide engineered proteins, yet its important to characterize
the modified protein and its impact on protein’s physical, chemical and biological properties.
1.1.3

Engineered proteins and their interaction with polymers

Subtle changes in proteins can result in customizable proteins with designed properties. New
methodologies are being used to make analogues of naturally occurring proteins that show better
stabilities, higher activities, and resistance to degradation with other desired properties. Given
the importance of proteins in biotech industry and pharmaceutical applications, the redesigned
proteins would likely be of great value with promising results. The field of chemical biology has
recently been surged with designer catalytic machines, comprising of functionally active
enzymes combined with synthetic polymeric scaffolds. The combination, typically called
bioconjugates, has been increasingly used in biotechnology and biomedical research for
widespread applications.
Here, we first investigated the structural details of protein-protein interactions in signal
transduction. Secondly, we attempted to understand how a small structural change in a protein’s
conformation affects its dynamics and interaction. Lastly, we studied the interaction of
2

engineered proteins with synthetic polymers and compared the activity of the free protein with its
polymeric conjugates.

1.2 Aims of the thesis
Following are the aims of the thesis:
1. To study how tyrosine phosphorylation of β3 integrin modulates its binding with c-Src.
2. To investigate binding and backbone dynamics of protein under topological constrain using
calmodulin as a model system.
3. To develop conjugates of Cel48F engineered protein with end-functionalized polymers.

1.3 Overview of the thesis
Following is an overview of the chapters in this thesis:
Chapter 3 (section 3.5) of the thesis provides insights into the binding of integrin with Src SH3
domain. We identified that the RGT motif of integrin sits between the RT and n-Src loop with
tyrosine serving as a bridge. We also showed that the C-terminal residues of integrin adopt a
polyproline type-II helix, which assists in binding of a non-PXXP motif to the Src SH3 domain.
Additionally, we proposed a docking model of integrin binding to SH3 domain, and explained
the importance of salt bridge formation of R760 of integrin CT with D117 of SH3.
Chapter 3 (section 3.6) expands on the results presented in chapter 3 (section 3.5). Here, we
identified and characterized the role of Src SH2 domain in binding to phosphorylated integrin.
The interaction of integrin β3 with Src SH3 is abrogated upon phosphorylation of two tyrosines
of β3CT, however recent studies have shown that phosphorylated integrin can remain bound to
Src. We hypothesize that αIIbβ3, phosphorylated at its β3 tail, interacts with c-Src SH2 domain, a
phosphotyrosine-recognizing domain. Our hypothesis is consistent with our preliminary NMR
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titration data. We identified the key residues of integrin involved in mediating the interaction
with Src SH2, that includes the phosphorylated tyrosine of β3 CT.
In Chapter 4, we constrained the topology of calmodulin (CaM) and studied its effect on internal
dynamics and molecular recognition by its binding partner, in particular smMLCK. For this
study, we first synthesized the constrained version of CaM (referred as cyclized CaM) by
introducing short cystine containing peptide sequences at its N- and C-termini. The formation of
disulfide bond between the two cysteines (Cys) facilitates the cyclization of the protein.
Intriguingly, we observed that the thermodynamic parameters of cyclized and linear (construct
having no additional constrain) version contribute differently to free energy of binding, keeping
ΔG constant. We also observed subtle differences in the order parameters of linear and cyclic
CaM, indicating increased backbone rigidity in the loop regions of cyclized version.
In Chapter 5, we reported development of polymer-protein conjugates of two fusion proteins
with end-functionalized polymers. We constructed two different fusion proteins comprising of
cutinase tag and SNAP tag respectively, with our target protein, Cel48F (family 48), an
important enzymatic member of Clostridium cellulolyticum cellulosome. We further compared
the cellulase activity of these enzymes in free and conjugated states.
Overall, these studies aimed to understand different protein-protein interactions and proteinpolymer interactions using diverse biophysical and biochemical techniques.
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Chapter 2. Characterization techniques
Different biophysical and biochemical approaches were pursued to conduct the studies presented
in this thesis. We primarily used Nuclear Magnetic Resonance (NMR) (except for chapter 4) for
structural analysis. Other biophysical techniques, including circular dichroism (CD), isothermal
titration calorimetry (ITC), differential scanning calorimetry (DSC), and mass spectroscopy
(MS) were used to further characterize the different protein systems. A brief description of each
technique is as follow:

2.1 NMR spectroscopy of proteins
NMR is a powerful tool to determine the structures and dynamics of the proteins in solution.
There has been an increasing interest in studying protein-protein interactions under physiological
conditions by using NMR spectroscopy. It is widely used to delineate the location of binding
interface in protein-protein interactions, and is useful in providing site-specific information on
backbone and side chain dynamics. Below are the brief discussions of the different NMR
techniques used in the thesis.
2.1.1 15N-HSQC (Heteronuclear Single Quantum Correlation) titration
15N-HSQC

based chemical shift mapping is uniquely suited to identify protein-ligand binding

interfaces. Owing to its high sensitivity, it is widely used in NMR. Titrating the unlabeled
compound into a solution of the labeled protein identifies the binding surface on

15N-labeled

target. The associated spectral changes in the 1H-15N HSQC spectra are monitored and mapped
onto the surface of protein (with known domain fold) to identify the binding site. The chemical
shifts are measured at each titration point. The chemical shift changes are converted to chemical

5

shifts perturbations, which are further plotted with respect to residue numbers [1]. Delta (ppm)
refers to the combined HN and N chemical shift changes according to the equation:
Eq. 1.

Δδ(HN,N) = ((ΔδHN)2 + 0.2(ΔδN)2)1/2,
where Δδ = δbound – δfree

During titration, apart from chemical shifts perturbations, its common to observe signal
broadening or complete disappearance of the peak. Such results point towards the complex
exchange regime of the proteins involved. The simple case of observing smooth chemical shift
perturbations in NMR spectra, suggest the system is under fast exchange (having a faster Koff
rate) and thus, we observe a weighted average of free and bound states. Other exchange
processes affect NMR, including slow and intermediate exchange and its possible to observe
different exchange regimes within the same biomolecule. If the Koff rate is slower than the
chemical shift difference between the free and bound states, then two different resonances are
observed, one from free and the other representing bound signal in the spectra. As the ligand is
titrated in, the free peak disappears with an increase in intensity of bound peak. The intermediate
exchange is defined when the exchange rate is similar to the shift difference, and the resultant
free and bound signals coalesce into one broad peak. Broadened peak, however, doesn’t always
indicate slow/intermediate exchange, and it is worthwhile to use other characterization
techniques to get more information[2].
2.1.2 Transferred NOESY
TrNOESY experiments are suitable for weakly associating systems, where the molecular weight
of the macromolecule is large compared to the ligand. It helps in identifying the bound
conformation of ligand, which are under fast exchange. Since the off rate is fast, the rate of NOE
build-up differs between the free and bound states. When the ligand is bound, it tends to tumble
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with the macromolecule, thus having a faster rate of NOE formation. This phenomenon is
observed by the presence of additional peaks in the NOESY spectra, when ligand is used in
excess concentration.
2.1.3 Paramagnetic Relaxation Enhancement (PRE) experiments
PRE experiments provide unique long-range distance (10-25 Å) information that can
complement NOEs, which are limited to distances of up to 5 Å. A paramagnetic label is
covalently attached to one of the binding partner to produce distance-dependent line broadening
in the NMR spectra. PRE profile (ratio of NMR signal intensities in the paramagnetic and
diamagnetic state) of tagged mutants is determined, and the line broadening of the residues are
used to map the orientation of the bound peptide. The line broadening is a result of increased R2
relaxation rates, described by Solomon-Bloembergen equation.
Eq. 2.

Where r is the distance between the electron and nuclear spins, τc is correlation time for this
electron-nuclear interaction, ωh is the Larmor frequency of this nuclear spin (proton) and K is a
constant.
2.1.4 Triple resonance Experiments
An important step in assigning the HSQC spectra is to perform the backbone/sequential
assignments using multidimensional NMR experiments. These set of experiments involve
transfer of magnetization between 1H, 15N and 13C atoms. The standard suite for backbone
assignment contains of experiments HNCA, HN(CO)CA, HNCACB, HN(CO)CACB, HNCO
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and HN(CA)CO. We can detect Cα, Cβ and CO groups of the given residue (i) and also for (i-1)
in certain spectra. The correlation and the information given by each spectra are as listed (the
signals from the nuclei in parentheses are not detected):

S.No.

Experiment

Information about i and i-1
residues

1.

HNCA

Cαi

2.

HN(CO)CA

Cαi-1

3.

HNCACB

Cαi

Cαi-1

4.

HN(CO)CACB

Cαi-1

Cβi-1

5.

HN(CA)CO

COi

COi-1

6.

HNCO

COi-1

Cαi-1

Cβi

Cβi-1

Table 2.1. Standard suite for backbone assignments. The above experiments are performed in
pairs to assign the Cα, Cβ and CO groups of the i and i-1 residues.
Experiments 1&2, 3&4, 5&6 are compared in pairs to give information about the residue (i) and
the preceding residue (i-1). For example, HNCA spectrum gives information about residue (i)
and (i-1). The (i-1) residue is sequence confirmed by comparing the chemical shifts of the peaks
in HNCA and HN(CO)CA spectra.
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Figure 2.1 Triple resonance experiments for backbone assignments. The arrows indicate transfer
of magnetization between the atoms involved. The figure was modified from [3].

2.1.5 NMR Relaxation experiments
Relaxation can be defined as the return of magnetization to its equilibrium state. Predominantly,
we observe T1 and T2 relaxation:
•

T1 relaxation (also known as longitudinal or spin-lattice relaxation time) is the rate at
which z component of magnetization returns to equilibrium after perturbation.

•

T2 relaxation (also known as transverse or spin-spin relaxation time) is the rate at which
xy component of magnetization returns to equilibrium after perturbation.
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Figure 2.2 The net nuclear magnetization M0 is aligned along the z axis. When irradiation
begins, all of the individual nuclear magnetic moments become phase coherent, and this phase
coherence forces the net magnetization vector M to process around the z axis. (a) Longitudinal
relaxation causes recovery of the longitudinal (z) component of magnetization (from black to
grey) toward M0, at an exponential rate with time-constant T1. (b) Transverse relaxation causes
shortening of the transverse component of magnetization (from blue to red), at an exponential
rate with time-constant T2. The figure was taken from [4].
Another relaxation parameter commonly studied is the heteronuclear nuclear Overhauser effect
(NOE) where we saturate the 1H signals and observe the associated changes in 15N signal. These
three relaxation parameters serve to determine the dynamics of the proteins in solution.
In order to relate T1, T2 and NOE with dynamics, its worth to mention the spectral density
function (J(ω)). J(ω) describes the effect of motion on relaxation rate and is further related to S2,
the order parameter. S2 is the generalized order parameter, which describes the amplitude of fast
motions experienced by the individual NH bond vectors. High S2 values, approaching 1, indicate
limited motions and greater rigidity, whereas lower values indicate increasingly larger amplitude
motions and greater flexibility.

2.2 Circular Dichroism (CD)
Circular dichroism is an excellent tool to determine the secondary structure of proteins. It
estimates the likelihood of a protein being in a helix, beta sheet or in random coil. Each
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secondary element gives a characteristic CD spectrum in the far UV spectral region (190240nm). α-helical proteins have negative bands at 222 nm and 208 nm and a positive band at 193
nm. Proteins with β-pleated sheets have negative bands at 218 nm and positive bands at 195 nm,
while disordered proteins have a negative band near 195 nm. Additionally, extended 310 helix or
poly-proline type II helix gives a negative band around 200nm and weaker positive band near
217nm [5].

Figure 2.3 Representative CD spectra of different secondary structures. Solid line, α-helix; long
dashed line, anti-parallel β-sheet; cross dashed line, extended 310-helix or poly (Pro) II helix;
short dashed line, irregular structure. The figure was taken Kelly S.M. et al., Biochimica et
Biophysica Acta - Proteins and Proteomics, 2005 [5].

2.3 Calorimetric techniques
2.3.1 Isothermal Titration Calorimetry (ITC)
ITC is a quantitative technique that can determine the complete thermodynamic profile (n, K,
ΔH and ΔS) of the interaction in a single experiment. It measures the heat change on formation
of a complex, when a ligand (L) is injected into the macromolecule (M) [6]. The heat released or
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absorbed upon each injection of a ligand is measured with respect to the reference cell containing
only the buffer. The raw data includes the plot of heat change required to maintain isothermal
conditions between the sample and the reference cell. The individual peaks are further integrated
and plotted with respect to total ligand-protein ratio to give the sigmoidal binding curve. The
binding enthalpy (ΔH) is calculated by measuring the total heat change, while the slope of the
curve gives the association constant (Ka) [7]. These parameters are further used to calculate
Gibbs free energy (ΔG) and entropy of binding (ΔS) using the following equation:
Eq. 3.

ΔG

= - RT lnKa

ΔG

= ΔH

binding

binding

- TΔS

binding

2.3.2 Differential scanning calorimetry (DSC)
DSC is a thermal technique, used to characterize the stability of the proteins. It measures the heat
change required to denature the protein and is useful in calculating the Tm, the thermal transition
midpoint of proteins. The Tm is the temperature at which the proteins have equal concentrations
of native and unfolded conformations (at equilibrium). The reference and the sample cells are
maintained at the same temperature as they are heated. The difference in the amount of heat
required to maintain the temperature of sample cell equivalent to that of reference cell is plotted
with respect to temperature.

2.4 Mass spectrometry
Mass spectrometry (MS) involves separation of molecules according to mass/size ratio. While
intact protein MS is routinely used to verify the identity of proteins, the approach of MS/MS
(alongwith with the use of trypsin digestion) allows identification of protein sequences and
localization of sites of modifications.
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Chapter 3. Integrins and its interaction with c-Src kinase
3.1 Integrins
3.1.1 Architecture of integrins
Integrins are a family of αβ heterodimeric receptors that act as cell adhesion molecules
connecting the extracellular matrix (ECM) to the actin cytoskeleton[1]. Each integrin subunit, α
and β, contains a large extracellular domain, a transmembrane (TM) domain, and a short
cytoplasmic tail. The extracellular head of integrins is composed of several domains- the α
subunit is composed of a propeller, a thigh, and two calf domains while the β subunit consists of
a PSI domain, a hybrid domain (with an inserted I/A domain), four I-EGF domains, and a tail
domain[2]. On the contrary, the cytoplasmic tails of α and β subunits are small (Figure 3.1),
which are connected to the extracellular head via single spanning trans-membrane helix[3].

Figure 3.1 Architecture of integrin αIIbβ3 and schematic representation of integrin activation. In
inactive state, the α and β subunits are in close association with headpiece in a bent
conformation. Subsequent to integrin activation, the two subunits are separated and the
headpiece straightens up, resulting in an extended integrin conformation. The α subunit is shown
in green and the β subunit in violet. The figure was modified from Moser, M. et al., Science,
2009 [4].
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3.1.2 Integrin signaling

Figure 3.2 Bidirectional Integrin signaling. The right panel shows the inside-out signaling while
the left panel represents the steps involved in mediating outside-in signaling. The figure was
taken from Shattil, S.J. et al., Nat Rev Mol Cell Biol, 2010 [5].

Integrins have unique characteristic of signaling bidirectionally, termed as inside-out and
outside-in signaling (Figure 3.2). Of the 24 different integrin receptors, assembled form 18 α and
8 β subunits, αIIbβ3, an archetypical representative of the class, regulates platelet aggregation and
serves as a molecular scaffold interacting with various extracellular and intracellular binding
partners [1]. Unstimulated platelets express αIIbβ3 in a conformation inaccessible to ligands,
preventing platelet-platelet interaction [3, 6]. In inactive state, the α and β subunits are in close
association with the headpiece in a bent conformation. Inside-out signaling, initiated by
separation of heterodimeric cytoplasmic tails cause an overall conformational change that
propagates across the membrane to the extra-cellular domain of the receptor [3]. The
extracellular domain of αIIbβ3 binds to its ligands with a high affinity and couples the platelets
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together to form an aggregate [3, 6]. An increase in ligand binding induces a cascade of signaling
events into the cell, collectively referred to as outside-in signaling[1]. The integrin β3
cytoplasmic tail (CT) is involved in propagation of outside-in signaling by binding to protein
tyrosine kinases (PTKs) and other signaling proteins [1, 7, 8].
3.1.3 Role of β3 Cytoplasmic tail in signaling

Figure 3.3 Binding of different adaptor proteins along the sequence of β3 cytoplasmic tail. The
lines indicate the motifs involved in binding to β3 tail. Tyrosine-bearing motifs are colored in
blue. The figure was modified from Legate, K.R. et al., J Cell Sci, 2009 [9].
β3 cytoplasmic tail is devoid of any catalytic activity but is composed of 47 residues comprising
of various motifs to which many of the proteins and kinases have been shown to bind (Figure
3.3)[9]. The different motifs include the membrane proximal HDRK motif, known to bind
skelemin, FAK and paxillin [10, 11]; the adaptor binding tyrosine-bearing motifs, namely,
NPXY and NXXY. Upon integrin activation, these tyrosines get phosphorylated and act as a hub
for proteins containing PTB domains, like Shc, DokI, and many others [12, 13]. More recently,
the C-terminal RGT motif has been shown to bind Src kinase. This interaction between integrin
and Src kinase is identified to have important role in outside-in signaling and has been a subject
of intensive research [7, 14, 15].
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3.2 Src kinase
3.2.1 Structural organization of Src

Figure 3.4 Structural representation of full length Src (PDB: 2SRC)[16]. The different domains
are color coded as pink: SH3 domain, cyan: SH2 domain, blue: catalytic domain, green: pY527
bearing C-terminal tail.
c-Src belongs to the family of Src family protein tyrosine kinases (SFKs), other members include
Fyn, Yes, Blk, Fgr, Hck, Lck, Lyn, and Yrk. c–Src, Fyn and Yes are ubiquitously expressed
while other members are expressed in specific tissues. All the members are structurally similar
and consist of SH3, SH2 and kinase domain [17].
The c-Src kinase is a multi-domain protein tethered to the plasma membrane by a N-terminal
myristoylation sequence [16]. It consists of a (i) unique domain (ii) SH3 domain, (iii) SH2
scaffold domain, and (iv) catalytic kinase domain, followed by a tyrosine (Y527) containing Cterminal regulatory sequence. The intramolecular interactions between the domains including (i)
the interaction between the SH3 domain and the linker connecting the SH2 and kinase domains,
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and (ii) the binding of SH2 domain to the phosphorylated Y527 at the C-terminal tail of the kinase
domain, maintain Src in a resting state with a closed conformation [18]. v-Src, the first oncogene
isolated from Rous Sarcoma Virus, was found to lack the C-terminal region that contains Tyr527,
making it continually active [19].
Typically, Src is maintained in an inactive state, but gets activated transiently during cellular
events such as mitosis, or upon adhesion of platelets to fibrinogen [20].Abnormal activation of
Src, either by mutation (as in v-src) or loss of regulatory control, can lead to drastic results with
repercussions in several cancers, including colon and breast cancer [21].
3.2.2 Regulation of Src

Figure 3.5 Model of c-Src activation by β3. The figure was taken from Huveneers S., et al.,
Scientific World Journal, 2010 [21].
The tyrosine phosphorylation status of Src regulates its activity, the key residues being Y416 and
Y527. Phosphorylation of Y416 activates the kinase whereas when Y527 is phosphorylated, it serves
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as a negative regulator of Src activity. Csk, a C-terminal Src kinase associates with Y527 of c-Src;
the phosphorylated Y527 further interacts with SH2 domain of Src, suppressing Src activity [16,
22]. On the contrary, PTP-1B, a phosphatase dephosphorylates Y527, relieving this inhibitory
interaction [8, 18]. Various factors, including association of Src with its binding partners, trigger
trans-autophosphorylation of Y416 (present within the activation loop of Src), resulting in an
increased catalytic activity of Src kinase (Figure 3.5).

3.3 Role of integrins in Src activation
Several studies have shed light on the importance of interaction of integrins with Src. The
interaction has been implicated in platelet adhesion, cytoskeletal reorganization and bone
remodeling. Integrins (upon its interaction with the extracellular matrix) cluster and congregate
several signaling and adaptor proteins [1, 23]. These sites of integrin clusters are involved in
formation of focal adhesions that regulate diverse arrays of cellular functions such as cell
motility, migration, differentiation and proliferation [1]. One of the initial events that occur upon
integrin activation is the increase in catalytic activity of SFKs [24]. Src kinase plays an important
role in mediating integrin dependent adhesion signaling by phosphorylating other downstream
kinases and adaptor proteins. De Virgilio (2004) showed the close proximity of αIIbβ3 and Src in
living cells, using Bioluminescence resonance energy transfer (BRET) and bimolecular
fluorescence complementation (BiFC) [25]. Biochemical studies have emphasized that integrin
not only acts as a substrate for Src kinase [26] but is also believed to bind Src SH3 domain
through its terminal residues, in particular the RGT motif. However, until the beginning of the
current studies, it wasn’t clear as where the RGT motif binds the SH3 domain. The present study
was carried out to address this issue. A better understanding is warranted, as myriad of details
remains elusive about the integrin mediated Src activation.
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3.4 Clinical significance
Extensive studies of both, integrin and Src kinase, have established a critical role of this
interaction in thrombosis and hemostasis as well as in regulation of platelet adhesion [27].
Current pharmacological approaches to prevent platelet-dependent thrombotic complications of
cardiovascular disorders include αIIbβ3 antagonism with inhibitors of ligand binding at the
extracellular matrix [28]. A novel antithrombotic approach targeting of αIIbβ3 signaling at the
level of β3 extreme C-terminus using β3-derived membrane permeable myristoylated peptides has
been proven successful [29]. However, there is still an unmet need for more effective and safe
antiplatelet drugs for chronic indications. Our studies reveal not only the structural details of new
therapeutic targets for the treatment of thrombosis and neoplastic diseases, but also provide new
insights into understanding the molecular details of the fundamental process of platelet adhesion
and c-Src activation.
Outline
In this project, we focused our efforts in studying the association of β3 cytoplasmic tail with cSrc. Section 3.5 provides insights into the binding of integrin with Src SH3 domain. We
identified that the RGT motif of integrin sits between the RT and n-Src loop with tyrosine
serving as a bridge. We also showed that the C-terminal residues of integrin adopt a polyproline
type-II helix, which assists in binding of a non-PXXP motif to the Src SH3 domain.
Additionally, we proposed a docking model of integrin binding to SH3 domain, and explained
the importance of salt bridge formation of R760 of integrin CT with D117 of SH3.
Section 3.6 expands on the results presented in section 3.5. Here, we identified and characterized
the role of Src SH2 domain in binding to phosphorylated integrin. The interaction of integrin β3
with Src SH3 is abrogated upon phosphorylation of two tyrosines of β3CT, however recent
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studies have shown that phosphorylated integrin can remain bound to Src. We hypothesize that
αIIbβ3, phosphorylated at its β3 tail, interacts with c-Src SH2 domain, a phosphotyrosinerecognizing domain. Our hypothesis is consistent with our preliminary NMR titration data. We
identified the key residues of integrin involved in mediating the interaction with Src SH2, and
identified the integrin-binding interface on Src SH2. Further experiments are necessary to fully
characterize the interaction, and to expound its functional relevance in integrin-Src signaling
pathway.

3.5 Structural insights into the recognition of β3 integrin cytoplasmic tail by
the SH3 domain of Src kinase
3.5.1 Overview
Shattil and co-workers [7, 8] have shown that outside-in signaling in platelets is mediated by a
direct interaction of carboxyl terminus β3 integrin with SH3 domain of Src kinase. Src SH3
domain, has been extensively studied and structurally characterized in both free and ligand
bound states (PDB: 1RLQ, 1QWF, 1NLP). It consists of two antiparallel β sheets positioned at
right angles to one another. The β strands are linked via RT loop, n-Src loop, distal loop, and a
short 310-helix [30, 31]. In general, SH3 domains are known to favor peptides bearing a PxxP
motif [32]. The PxxP motif adopts a polyproline type II (PPII) helix and binds between the RT
loop and n-Src loop. The selectivity of these peptides is further enhanced by basic residues,
arginines or lysines, which flank the core motif. In addition, other mechanisms may contribute
towards the specificity of this interaction with the SH3 domain [33]. Although two classes of
peptides, class I—(R/K)xxPxxP and class II—PxxPx(R/K), [32-34] are considered as canonical
SH3 binding targets, accumulating evidence suggests that SH3 can also recognize non-PxxP
motifs [32, 35, 36]. The exact molecular details of such recognition still remain unclear.
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However, some non-PxxP peptides have been shown to occupy the same interface as PxxP
motifs [37].
In this project, we present the NMR data and a docked model of SH3 with cytoplasmic integrin
β3. We also show that the C-terminal RGT motif of β3 adopts a partial PPII type helix facilitating
its interaction with the RT and n-Src loops of SH3 in an orientation opposite to that obtained
from X-ray studies [14]. Finally, NMR titration studies demonstrate no interaction with the
phosphorylated β3, supporting the idea of a constitutive interaction between nonstimulated/resting (non-phosphorylated) β3 integrin and the SH3 domain of Src kinase.
3.5.2 Materials and methods
Peptides
β3 heptapeptide (NITYRGT762), mono (ATSTFTNITpYRGT762), and bi-phosphorylated
(RAKWDTANNPLpYKEATSTFTNITpYRGT762) C-termini of β3 (MP-Cβ3 and BP-β3
respectively) were synthesized chemically (Genemed Synthesis; NEO-peptides).
Expression and purification
Cloning, expression, and purification of cytosolic β3 was done as described elsewhere [3]. The
human Src SH3 (residue 80–144) in pGEX-4T1 vector was expressed in BL21(DE3) after
induction with 1mM IPTG. To produce
M9 minimal media containing

15NH

4Cl.

15N-isotopically

labeled Src SH3, cells were grown in

GST-tagged SH3 was purified in PBS buffer (140mM

NaCl, 27mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4, pH 7.2) using Pierce Glutathione Agarose
resin (Thermo Scientific). SH3 was eluted by either cleavage with thrombin or by using 10mM
glutathione in PBS buffer. The eluate was further purified through HiLoad 16/60 Superdex 75
column (GE Healthcare) equilibrated with PBS buffer.
NMR spectroscopy
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All experiments were performed at 25°C using 0.1mM protein samples (unless otherwise
mentioned), on 600 MHz magnet (Agilent) equipped with inverse-triple resonance cold probe.
15N-HSQC

titration

Concentrated stock solutions of β3 peptides were prepared in the same buffer as Src and added to
the 15N-labeled SH3 domain at different peptide to protein molar ratios. Each data point was also
reverse titrated beginning from the saturated conditions for the peptides. Experiments were
performed at pH 5.8. The SH3 spectra at different pH were collected as a negative control. All
the spectra were collected with 2048 complex data points in t2 and 128 increments in t1
dimensions and zero filled to 2048 x 1024 data points. The spectra were processed with
NMRPipe and analyzed by CCPN software suite [38]. Chemical shift assignments for SH3
domain were obtained from BMRB database entry 3433 [31]. The shifts were adjusted to match
our experimental conditions.
Transferred NOE
β3 heptapeptide was mixed with GST-fused SH3 at pH 6.5. Different peptide to SH3 ratios were
investigated to find the optimal one for NOE transfer in two-dimensional proton NOESY
experiments with the mixing time of 400 ms. A negative control with just the GST tag was
performed under the same conditions at an optimized heptapeptide to GST ratio of 200 to 1.
Partial 1H resonance assignments for the heptapeptide were obtained by collecting TOCSY
(mixing time of 70 ms) and NOESY (mixing time of 400 ms) spectra.
Paramagnetic Relaxation Enhancement (PRE) experiment
In order to introduce a spin label, β3 mutant was constructed with an additional cysteine residue
after the terminal YRGT sequence using QuikChange site-directed mutagenesis kit (Agilent).
Prior to the reaction, the mutant was reduced by 1mM TCEP, which was subsequently removed
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by washing on a PD-10 column (GE Healthcare). The reduced β3 mutant was allowed to react
overnight with either an excess of cysteine specific spin label, 3-maleimido-PROXYL, hereafter
referred to as mProxyl (Sigma-Aldrich), or 1-oxyl-2,2,5,5-tetramethylpyrroline-3-methyl)
methanethiosulfonate, hereafter referred to as MTSL (Alexis Biochemicals). The reactions were
performed at room temperature at a pH of 7.0. The unreacted spin label was separated from the
tagged mutant by reverse phase HPLC on PROTO C4 column (The Nest Group). Attachment of
the tag was confirmed through mass spectrometry.

15N

-HSQC spectrum of SH3 in the presence

of tagged β3 mutant (as well as a control with untagged mutant) was collected under the same
conditions as used for wild type β3 titrations.
Circular dichroism
CD experiments were done on PiStar 180 Spectrometer (Applied Photophysics, UK). The sample
was prepared by dissolving β3 heptapeptide in 20 mM phosphate buffer at pH 6.5. Spectrum was
collected in the far UV range at 25°C with a step resolution of 0.5 nm, bandwidth of 3.0 nm and
data averaging of 30 s/point.
Electrostatic potentials mapping
The potential files used for mapping were prepared from the respective PDB files by Adaptive
Poisson–Boltzmann Solver (APBS) [39], a program that maps the electrostatic potential energy
based on Poisson–Boltzmann equation. The resultant (.pqr and.in) files from pdb2pqr webserver
served as input for APBS calculations. APBS webserver as well as Chimera’s APBS built-in tool
were used to prepare the electrostatic potential maps, which further rendered the electrostatic
surface using Chimera’s Electrostatic Surface Coloring tool. Alternatively the surface potential
was also directly mapped using Coulombic surface mapping.
3.5.3 Results
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Previous studies have identified the C-terminal RGT762 motif of β3 integrin [7, 27] as the binding
site for Src kinase through its SH3 domain. Hence we decided to map the binding site of this
interaction onto the surface of SH3 using solution NMR. First, the full length unlabeled
β3 cytoplasmic tail (hereafter referred to as β3CT) was titrated against 15N -labeled SH3. The 15N
-HSQC spectra of SH3, shown in Figure 3.6, clearly indicate significant chemical shift
differences when compared to the spectrum from free protein (shown in black). This titration
was performed at an SH3 to β3 molar ratios of 1:1, 1:3, and 1:5 while maintaining a constant pH
throughout the experiment. The observed chemical shift differences, shown in Figure 3.7 (a),
were concentration dependent, reproducible, and specific to the interaction. Additionally, control
experiments with the SH3 domain at different pH showed no similar effect, validating the
perturbations being a consequence of binding. Amino acids affected the most, belong to the RT
loop (residues R95 to L100) and the n-Src loop (E115 to W118), with Y131 perturbed in isolation. The
RT loop amide peaks (R95, T96) were broadened upon titration, a manifestation of conformational
exchange [4] (Fig. 3.7(c) and also shown in Fig. 3.8); while the peak intensities corresponding to
the residues from the n-Src loop remained unaffected, suggesting a single conformation within
this loop. Next, we tested β3 heptapeptide, composed of the last seven β3 residues containing the
RGT motif. Chemical shift perturbation pattern obtained with β3 heptapeptide (Fig. 3.7 (b))
closely resembled the one obtained with the full-length β3CT. The insets in Figure 3.7 represent
the mapping of the chemical shifts onto the surface of SH3 domain (PDB: 1SRL) in the presence
of full-length β3CT (Fig. 3.7 (a)) and β3 heptapeptide Fig. 3.7(b). The similar binding interfaces
between the two confirms that the C-terminal motif of β3 is sufficient to define its binding to Src
SH3 domain.
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Figure 3.6 The superimposition of 15N -HSQC spectra of Src SH3 (shown in black) in the
presence of varying molar excess of β3CT as shown in blue (1:1), green (1:3) and red (1:5). Also
shown to the right are several individual residues displaying significant shifts.
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Figure 3.7 (a) Chemical shift differences in SH3 HSQC spectra upon β3CT binding at different
molar ratios. Bars are colored according to the different ratios as presented in Figure 3.6; Delta
(ppm) refers to the combined HN and N chemical shift changes according to the equation:
Δδ(HN,N) = ((ΔδHN2 + 0.2(ΔδN)2)1/2, where Δδ = δbound − δfree; The inset shows the chemical shift
differences (obtained from 1:5 ratio) mapped onto the surface of SH3 domain (PDB: 1SRL),
where the darker color represents the residues maximally affected. (b) Chemical shift differences
obtained from the 15N HSQC spectrum of SH3 upon binding to β3 heptapeptide also at 1:5 ratio,
further mapped onto the surface of SH3 domain (inset). (c) Paramagnetic relaxation
enhancement data of the backbone amide groups of SH3 in the presence of PRE tagged β3CT
(green) in comparison to the untagged β3CT (orange). The asterisk mark represents proline
residues.
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Figure 3.8 Superimposition of the 15N -HSQC spectra of SH3 in the presence of wild type β3CT
(orange) and mutant with paramagnetic tag attached to its C-terminus end (green). The inset
shows surface representation of the docked SH3 model with the heptapeptide (orange) and
heptapeptide with PRE tag (green, attached tag is shown in yellow).
We further used the chemical shifts mapping approach to test the influence of tyrosine
phosphorylation, a characteristic feature of activated β3 receptor, [40], on its binding to Src
kinase. These titrations were performed against 15N-labeled SH3 with mono-(pY747) or bi(pY747&pY759)-phosphorylated β3-derived peptides (MPCβ3 and BPβ3 respectively, refer to the
Material and Methods section). Since no chemical shift differences were found in either case,
even at a high molar ratio of 1 to 5 (Fig. 3.9), we concluded that tyrosine phosphorylation
prevents SH3 from binding to β3. This finding is consistent with the previously suggested
mechanism of constitutive interaction of Src with unactivated/resting, non-phosphorylated
integrin β3 [7].
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Figure 3.9 Superimposition of the 15N -HSQC spectra of SH3 obtained alone (green) and in the
presence of peptides: C-terminus monophosphorylated β3 (MPCβ3) (blue), and biphosphorylated
β3 (BPβ3) (red).
We additionally carried out Paramagnetic Relaxation Enhancement (PRE) experiments to
ascertain the orientation of bound integrin. A paramagnetic spin label was attached to the
β3 mutant containing a cysteine residue added to its C-terminal end (Figure 3.10). The nitroxide
radical from the spin label attenuates peak intensities of nearby residues allowing direct mapping
of its location onto the binding surface. Since the label is attached next to the RGT motif,
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maximum attenuation is expected for SH3 residues adjacent to the ones involved in binding of
this motif. To test whether the addition of a paramagnetic tag affected the interaction, we
compared the spectra of SH3 in the presence of wild type β3CT and its tagged mutant (Fig. 3.8).
Since no significant differences were observed we proceeded with the PRE analysis to study this
interaction.15N -HSQC spectra were collected at an SH3 to β3 mutant ratios of 1:2 and 1:4. Peak
intensities for SH3 in complex with the tagged β3 mutant were normalized to the intensities of
SH3 in complex with the untagged mutant. Maximum attenuation was observed for the residue
N135 (with its side chain signals broadened beyond detection; Fig. 3.8) and a moderate decrease
for Y136 suggesting their close proximity to the tag. A moderate decrease in the intensities of the
n-Src loop also confirmed its positioning near-to the β3 RGT motif, while the RT loop was less
affected, showing similar intensities to the bound untagged β3 (Fig. 3.7 (c), shown in orange).
Attaching the tag to a cysteine residue present at the end of the C-terminus makes it quite
flexible, hence preventing the quantitative analysis of the PRE data for structure calculations.
However, having the N135 residue from the SH3 domain in close proximity to the nitric oxide
from the tag, allowed us to reliably predict the orientation of the RGT motif within the SH3
binding interface.
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(a)

MTSL

m-proxyl
(b)

Figure 3.10 (a) Chemical structure of PRE tags: 3-maleimido proxyl and MTSL. (b) MS
spectrum of m-proxyl tagged β3
To further define the molecular details of the complex, in particular, the conformation of integrin
C-terminus bound to the SH3 domain, we employed transferred NOE (trNOE). This method is
best suited to study weakly associating systems comprising of small ligands bound to large
molecules. NOESY spectrum of β3 heptapeptide, collected in the presence of GST-fused SH3 at
an optimized peptide to protein molar ratio of 200 to 1, demonstrates the additional peaks
manifesting the binding (Fig. 3.11 (a)). These peaks were absent in the control experiment with
GST alone. Although partial assignments for the bound heptapeptide were made, insufficient
amount of distance restraints deterred us from obtaining the complete structure of the complex.
As no medium-range NOEs characteristic for α-helical secondary structure were observed, we
speculate that upon binding the peptide exists as an ensemble of random coil and extended
conformers. The secondary structure of the heptapeptide was further probed by circular
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dichroism (CD). The spectra showed a negative band at 197 nm and a positive band at 229 nm
Fig. 3.11 (b), reflecting the presence of a left handed PPII helix. Molar ellipticities per residue
for these two bands are somewhat weaker for β3 heptapeptide when compared to the values
reported in literature for peptides adopting a polyproline type II helix conformation [41, 42]. This
suggests that β3 heptapeptide might adopt a partial PPII type helical conformation.

Figure 3.11 (a) Superimposition of the NOESY spectra obtained for β3 hepta-peptide alone
(blue) and in the presence of GST-SH3 (red). (b) Circular dichorism spectrum obtained for
β3 hepta-peptide shows a negative band at 197 nm and a positive band at 229 nm, typical for a
partial polyproline type II-like helix.
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Various models of β3 heptapeptide were generated (with or without C-terminal paramagnetic
label attached) using the Haddock (High Ambiguity data driven protein–protein DOCKing) web
server [43, 44] to investigate the binding of β3 heptapeptide to SH3 domain (PDB: 1SRL). The
ambiguous interaction restraints (AIRs) were defined by NMR titration and PRE experiments
with the starting conformation of the heptapeptide consistent with our trNOE and CD data.
Cluster analysis of the resulting 200 water-refined models reveals 72% (with the paramagnetic
tag) and 69% (without tag) of these models belong to a single cluster. Both clusters
accommodate very similar binding interfaces as shown in the inset of Supporting Information
Figure 3.8. The backbone root mean square deviation (RMSD) from the lowest energy model for
the conformers from the cluster with tag is 1.1 Å, while for the conformers from the cluster
without tag is 1.3 Å.
3.5.4 Discussion
The initial events in β3 integrin outside-in signaling rely on its association with the SH3 domain
of Src kinase. We have deduced the molecular details of this interaction using NMR. Chemical
shifts mapping experiments depict the C-terminus of β3 located between the RT and n-Src loops
of SH3 domain, with Y131 from the β4 strand serving as a bridge between the two. As per our
PRE results, the RGT motif binds to the pocket formed by the n-Src loop. The preceding NITY
motif makes occasional intermediate contacts with the RT loop rendering its conformational
heterogeneity.
The experimental data allowed us to obtain a reliable docked model of the complex using the
HADDOCK web server. We are certain that our docking model provides a more accurate
representation of the binding interface Fig. 3.12 (c) than the recent X-ray model (PDB: 4HXJ)
containing the RGT tri-peptide [14] (Fig. 3.12(d)) for the following reasons: (i) We have used
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the longer construct, full length β3 cytoplasmic tail, in addition to the heptapeptide. According to
our model, the RGT motif binds to n-Src loop while the remainder of the β3 tail extends into the
RT loop. The “fishing hook” arrangement presented in the X-ray structure, which places integrin
on top of SH3, would not explain the conformational exchange in the RT loop observed in our
titration experiments. Moreover, our CD data shows that the heptapeptide has a partial PPII
helix, a characteristic feature of SH3 binding ligands, which tend to interact between the RT and
the n-Src loops. (ii) We have attached the paramagnetic tag to the C-terminal end of RGT
sequence, which allowed us to orient the RGT motif unambiguously with respect to its SH3
binding pocket. If the orientation were to be as per the X-ray structure, we would have seen the
PRE effect opposite to the current site on SH3's surface. Moreover, the weak electron density
map, used to fit the small RGT tri-peptide, could easily lead to an ambiguous orientation. This
ambiguity is further accentuated by the following two observations form the X-ray structure: the
average B-factor for RGT is 67 Å2, much higher than that of the SH3 domain itself (13.5 Å2),
and the asymmetric unit of the crystal structure containing two SH3 molecules binds to a single
RGT peptide (Figure 3.13). (iii) Our model also supports the biochemical studies that have
clearly shown the importance of R760 from integrin β3 YRGT motif and D117, W118, and
Y131 residues from the SH3 domain. According to our model, the partial PPII characteristic of the
peptide allows arginine side chain from the RGT motif to be positioned between the aromatic
residues W118 and Y131 within the specificity pocket. This allows R760 to easily interact with
either of the residues, while no such interactions occur in the X-ray model. Additionally, the
guanidinium group of R760 forms a salt bridge with the side chains of either D99 or D117 or with
both, as shown by some conformers of the ensemble, while in the X-ray model this crucial
arginine exhibits predominantly hydrophobic contacts with a single backbone amide hydrogen
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bonded to D117. (iv) Furthermore, the electrostatic surface potential of SH3, presented for the
apo-domain in Figure 3.14(a) and for our model in Figure 3.14(c) provides a more plausible
binding opportunity that is driven by polar interactions between the negatively charged groove
on the SH3 surface and positively charged side-chain of R760, proving critical for the complex
formation [14] and shown to enhance selectivity (as an R/Kxx or xR/K addition) when linked to
PxxP, the canonical SH3 binding motif [33]. The surface potential for SH3 domain calculated
based upon the coordinates from the X-ray complex (PDB: 4HXJ), presented in Figure 3.14(b),
makes it electrostatically unfavorable to place the negatively charged carboxyl end of the peptide
into the negatively charged groove on SH3.
The X-ray structure of the inactive Src kinase (PDB: 2SRC) shows the linker connecting the SH2
and the kinase domains in close proximity to the RT and n-Src loops of SH3 domain [16]. The
question remains whether β3 binds to Src kinase in its inactive closed form in the presence of the
linker, and, if so, how does the linker affects its affinity for Src kinase. Or, alternatively, β3 might
bind to the open form, replacing the linker, thus preventing Src kinase from becoming inactive
and maintaining a small population of active kinase partially poised to start the activation process
induced by integrin microclustering.
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Figure 3.12 (a) β3 heptapeptide docked onto Src SH3 domain using HADDOCK program.
Chemical shift perturbations are mapped in purple. Additionally, the residue most affected by the
spin label is shown in orange. (b) Electrostatic surface potential of SH3 domain bound to β3
heptapeptide (colored with +6kT/e). (c) A ribbon representation of the binding interface obtained
from the docked model highlighting R760 which could make potential contacts with either D99 or
D117 in the specificity zone. (d) X-ray structure of the RGT peptide in complex with SH3 domain
(PDB: 4HXJ) comparatively showing the reverse orientation of the peptide.
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Figure 3.13 Electron Density for the RGT Peptide. The wire representation of protein is shown
in green while peptide atoms are shown in yellow. (PDB: 4HXJ)

Figure 3.14 The electrostatic surface (colored with +6 kT/e) of SH3 domain alone (pdb code:
1SRL, panel a) and our docked model with integrin β3 heptapeptide (panel c) are mapped using
the more rigorous Adaptive Poisson-Boltzmann Solver (APBS) with the electrostatic potential
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energy calculated based on Poisson-Boltzmann equation. The X-ray model (pdb code: 4HXJ,
panel b) is mapped using Coulombic Surface in an attempt to match its representation from the
article. [14]
In light of the proposed mechanism of outside-in signaling [18], where some integrin β3
molecules are primed for activation of Src kinase, the weak binding as observed from our trNOE
experiments seem pertinent. In addition, we have further investigated whether SH3 domain binds
to the phosphorylated β3 and found no interaction, suggesting that Src can be associated with
integrin through its SH3 domain only in the resting non-phosphorylated state of the receptor. We
believe that this weak but constitutive interaction would keep Src tethered to the integrin and
consequently bring two or more Src kinases to close proximity upon integrin activation via
clustering [7]. This, in turn, would aid in trans-activation of the kinase through autophosphorylation of Y418 in the Src activation loop.
3.5.5 Conclusions
In conclusion, our chemical shifts mapping data in concert with PRE, trNOE and CD studies
have confirmed the RGT762 motif of β3 integrin as the binding site for Src kinase. We have used
these data to generate a reliable model of the complex through docking. Furthermore, we have
shown that tyrosine phosphorylation of β3 cytoplasmic tail prevents it from binding to SH3,
corroborating the reports of a constitutive interaction between resting integrin β3 and Src kinase
[7].
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3.6 Identification and structural characterization of β3 integrin cytoplasmic
tail as a binding partner of c-Src SH2
3.6.1 Overview
In resting platelets, Src forms a complex with αIIbβ3 integrin through the interaction involving cSrc SH3 domain and the carboxyl-terminal region of the β3 cytoplasmic tail [7, 8, 14, 45]. When
the platelets gets stimulated, as exemplified by phosphorylation of Y747 and Y759 (present within
the β3CT), the activated β3 prevents its binding to the SH3 domain [45]. Interestingly, it was
found that the activated β3 could still be bound to Src, making it catalytically active [15]. Based
on the recent findings and our preliminary data, we hypothesized that phosphorylated β3 recruits
SH2, the phosphotyrosine-recognizing domain of Src, which we believe regulates Src activation.
Overall, our proposed work should serve as a foundation for structural understanding of integrin
mediated Src activation with focus on Src SH2 domain as a central key regulatory element.
The Src homology 2 (SH2) spans the region between the amino acids sequence 140- 250 in cSrc. It consists of a central β-sheet flanked by two α-helices. It is known to bind to pYEEI motif
with a strong affinity and can also bind peptides with two phosphorylated tyrosines [46, 47]. The
phosphorylation of second tyrosine, although not essential, increases the affinity of the binding
peptides. The phosphotyrosine binds into a deep pocket formed near the central sheet of SH2
domain, while the residues, C-terminal to the phosphotyrosine, bind to the region composed of
C-terminal residues of SH2. This region comprises of a hydrophobic pocket that binds to the
hydrophobic residues in Y+3 position, conferring specificity to the peptides that bind Src SH2
domain [48].
3.6.2 Methods
Expression and purification
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β3 was expressed and purified as previously [3]. Two mutants of β3 (Y747F and Y759F) were
prepared using Quikchange site directed mutagenesis kit. Tyrosine phosphorylation of β3CT and
its mutants was achieved in vitro by using Src kinase, as described by Anthis et al [49], and is
briefly described in next section. The Src SH2 domain (residues 143-245) containing pET28
SacB AP vector, generously provided by Pawson lab, was expressed in BL21 (DE3) cell line.
Purification of Src SH2 domain is performed according to the protocol from QIAGEN under
nondenaturing conditions followed by gel-filtration on HiLoad 16/60 Superdex 75 column in
20mM MES, 50mM NaCl, 1mM DTT buffer at pH 6.0. Cultures are grown in minimal media
with 15NH4Cl as the sole nitrogen source.
Phosphorylation of integrin tails by Src kinase
We used a similar protocol as described by Anthis et al [49]. Briefly, Src and β3 were added at a
ratio of 1:75 and the phosphorylation was performed overnight (~16hours) at RT in 50 mM Tris
pH 7.3, 20 mM MgCl2, 10 mM MnCl2, 2 mM ATP. Phosphorylated tails were separated from
unphosphorylated tails by HPLC and were identified by mass spectrometry (Figure 3.15) and
NMR.
BP
MP

NP

Figure 3.15 MS spectrum of β3 integrin tails by Src. The largest peak represents the bisphosphorylated β3; NP (Non phosphorylated, MW of 7739); MP (mono-phosphorylated, MW of
7819 including the additional 79 Da due to single phosphate moiety); and BP (bisphosphorylated, MW of 7899 with additional 158 Da due to double phosphate groups).
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NMR sample preparation
The heteronuclear NMR experiments were performed on uniformly 15N-labeled 0.1mM Src SH2
samples (unless mentioned otherwise), with or without binding partners (β3CT BP full length /
β3CT Y747F and Y759F and their phosphorylated versions/β3 derived phosphorylated peptide) at
different concentrations on Varian Inova 600 MHz equipped with inverse-triple resonance cold
probe at 30°C. The samples were prepared in pH 6 (unless mentioned otherwise) in the SEC
buffer as above, with 10% D2O and 1mM DSS acting as an internal standard. Similar
experiments were carried with non-phosphorylated β3CT as a control. 15N-HSQC titrations were
also performed by titrating non-labeled Src SH2 into

15N-labeled

phosphorylated β3 CT, to

confirm binding from both sides. All the NMR data was processed by nmrPipe and analyzed by
CCPN software suite. The structure of apo v-Src SH2 has been solved with NMR (BMRB
accession: 6503) [50]. Using similar buffer conditions we were able to transfer about ~70% of
assignments. Chemical shift assignments for β3BP were obtained from the previous studies
performed by our lab [51].
3.6.3 Results
Through NMR binding studies, we demonstrate that SH2 domain of Src can interact with bisphosphorylated β3CT. Phosphorylation of β3CT was achieved using a previously reported in vitro
assay and confirmed using MS. Bi-phosphorylated tail was further separated using reverse phase
HPLC.

15N-labeled

β3BP was titrated with NL Src SH2 at 1:1, 1:3 and 1:5 ratio of β3BP to Src

SH2 (Figure 3.16). The signals from residues

747

pYKEATST753 and R760 were broadened while

G761 showed chemical shift perturbations (Figure 3.17). On the contrary, pY759 showed minimal
perturbation. Additionally, control experiments with 15N-β3NP showed no such effect.
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Further insights about the binding of β3BP to the Src SH2 domain were obtained by recording
15N-HSQC

spectra of Src SH2 in the presence β3BP and its (YtoF) mutants. Increasing

concentration of β3BP when titrated into

15N-labeled

Src SH2 domain showed reproducible and

consistent chemical shift perturbations pattern at 1:1, 1:3 and 1:5 ratio, as shown in Figure 3.18.
Additionally, we observed peak broadening effect in HSQC spectra, and few peaks disappeared
completely. The associated chemical shift perturbations and broadened peaks were monitored
and when mapped on the surface of the known structure (pdb: 1HCS) formed a continuous
binding region onto the surface of SH2 (Figure 3.19).
Furthermore, we phosphorylated two different mutants, β3 Y747F and β3Y759F, and studied the
effect of mono-phosphorylated β3 on the binding pattern. Despite some subtle differences in the
chemical shift perturbation pattern, the spectral analysis of Src SH2 in the presence of β3 Y759F
(MP) showed a similar peak broadening effect as wild type (Figure 3.20 a). On the other hand,
addition of β3 Y747F (MP) resulted in spectral changes, whereby the peaks, which were
broadened in wild type, now either reappeared or exhibited perturbations when compared with
the spectra of apo Src SH2 (Figure 3.21 b). These results indicate that the presence of second
phosphorylated tyrosine is not entirely essential, however, it may improve the overall binding of
integrins to SH2 domain.
Additionally, we also performed ITC experiments using a peptide corresponding to biphosphorylated integrin (RAKWDTANNPLpYKEATSTFTNITpYRGT762) as the titrant. We
reached saturation within a few initial injections, thus further optimization is required to obtain a
correct estimation of dissociation constant and other thermodynamic parameters.
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β3BP+SH2
1:0
1:1
1:3
1:5

pY747

pY759

Figure 3.16 The superimposition of 15N-HSQC spectra of β3BP (shown in black) in the presence
of varying molar excess of Src SH2 as shown in blue (1:1), green (1:3) and red (1:5).
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Figure 3.17 Chemical shift differences in β3CT HSQC spectra upon SH2 binding at 1:5 molar
ratio. The asterisk mark represents proline and overlapping residues. The x represents weak
intensity signal in apo form, thus not included in analysis.
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SH2 + β3 BP
1:0
1:5

Figure 3.18 The superimposition of 15N-HSQC spectra of Src SH2 (shown in black) in the
presence of β3 BP at 1:5 ratio (red).
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1:1
1:3
1:5

Figure 3.19 Chemical shift differences in 15N Src SH2 spectra upon β3 BP binding at varying
ratios (Green 1:1, blue 1:3 and red 1:5 molar ratio. Delta (ppm) refers to the combined HN and N
chemical shift changes according to the equation: Δδ(HN,N) = ((ΔδHN2 + 0.2(ΔδN)2)1/2, where
Δδ = δbound − δfree. The inset shows the chemical shift differences and broadened peaks
(obtained from 1:5 ratio) mapped onto the surface of SH2 domain (PDB: 1HCS).
(b)

(a)

SH2
SH2 + β3MP
SH2 + β3BP

SH2
SH2 + β3MP
SH2 + β3BP

Figure 3.20 (a) The superimposition of 15N-HSQC spectra of Src SH2 (shown in black) in the
presence of β3 Y759F (MP) (green) (b) The superimposition of 15N-HSQC spectra of Src SH2
(shown in black) in the presence of β3 Y747F (MP) (blue). The 15N-HSQC spectra of Src SH2 in
the presence of β3 BP (red) is shown for comparison.
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3.6.4 Discussion
The amino acids sequence following the phosphotyrosine residue play a vital role in defining the
specificity of the peptides binding SH2 domain [52]. The pYEEI, a high affinity peptide has an
optimal sequence for SH2 binding whereby residue Ile at +3 position sits into the hydrophobic
pocket [48]. Integrin β3 has two tyrosines present within its cytoplasmic tail, having pYKEATS
and pYRGT motifs. Owing to the presence of a glutamate at +2 position (similar to YEEI) and
alanine, a hydophobic residue at +3 position of the pY747, we believe SH2 preferentially binds to
it and allows it to sit into the phosphotyrosine-binding pocket of SH2.
Recently, Wu et al reported that activated β3 remain bound to c-Src, subsequent to which there is
an increase in Src activity [15]. We, for the first time, identified the role of SH2 domain in
binding to activated β3, characterized by phosphorylation of Y747 and Y759. It is imperative to
further study the molecular and structural details of this interaction in signaling pathway, and
within the more complex cellular context.
In resting state, the intramolecular interaction between SH2 domain and pY527 bearing Cterminal tail of the kinase domain, maintain Src in a closed conformation [18]. Although, the
sequence of events involved in β3 mediated Src activation remains unclear, Src kinase activation
has been achieved by disrupting this relatively weak interaction by using high affinity
phosphopeptides [53]. On similar lines, we believe that phosphorylated β3 can displace pY527
from SH2, thereby activating Src. It is logical to reason that binding of β3 can directly displace
pY527 or it may affect the dynamics/conformation of SH2, and ultimately increasing the kinase
activity. Further experiments are needed to investigate the role of β3 in displacing pY527.
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3.7 Conclusions and Future directions
Because the SH2 domain is a known phosphotyrosine-recognizing domain, we tested the ability
of the phosphorylated β3 to interact with the SH2 domain of c-Src. These results demonstrate that
the phosphotyrosines and its adjacent residues are critical in mediating interaction between the
SH2 domain and integrins. However, further experiments are necessary to confirm and
characterize the interaction. In addition, we are proposing to utilize Nanodiscs, a discoidal
nanolipoprotein with a phospholipid bilayer covered by an amphipathic protein coat. Nanodiscs,
incorporated with and without phosphorylated β3 will be titrated into

15N-Src

SH2 to study the

interaction under membrane mimetic conditions.
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Chapter 4. Binding and Backbone Dynamics of Protein under
Topological Constrain: Calmodulin as a Model System
4.1 Introduction
Over the last twenty years, hundreds of cyclized proteins (i.e., N- and C- termini linked
together), have been identified in nature and implicated in a wide range of biological activities
[1, 2]. Owning to their unique folding topology, circular proteins show remarkable thermal,
chemical, and enzymatic stability [3, 4]. A few cyclic derivatives of polypeptides and larger
proteins have been developed using various methods [4-6], resulting in enhanced resistance
toward denaturation and proteolysis when compared with their linear counterparts. While much
progress has been made in elucidating the structure and corresponding biological activities of
circular proteins [7, 8], the physical basis of how the circular topology modulate the functions of
proteins (e.g., molecular recognitions) remain elusive. Particularly, how does the topological
constrain affect the protein’s internal dynamics and subsequently, their thermodynamic
properties. It is conceivable that the circularization of a protein with flexible ends may reduce its
conformational entropy. Since the changes of protein conformational entropy are potentially
linked to the free energy of protein-ligand association, the circularization may change the
binding affinity of the protein to its receptor. Herein, we attempt to understand the effect of
circularization on protein dynamics and molecular recognition using calmodulin (CaM) as a
model system.
The use of CaM as the model system is based on the fact that it is an extensively studied protein
known to interact with a variety of target proteins involved in many aspects of cellular function
[9]. CaM is composed of two, N- and C-, globular lobes, each containing a pair of helix-loophelix motifs (EF-hands) that bind calcium ions. When bound to four calcium ions, CaM adopts a
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dumbbell configuration comprising of two lobes tethered by a central flexible linker (Figure 4.1
(a)) [10, 11]. Upon binding to target proteins, the flexibility of the central linker (residues 78–81)
allows the two lobes to adjust their relative orientation, resulting in the collapse of CaM into a
more rigid globular fold (Figure 4.1 (b)) [12]. This mechanism is sometimes referred to as the
wrap-around mode of binding [12, 13]. Since CaM undergoes a large conformational change
upon binding, we wanted to investigate whether cyclization affect the binding and dynamic
behavior of calmodulin.
(a)

(b)

Figure 4.1 (a) NMR structure of Calmodulin. The N- and C-lobe are connected by the central
linker (b) NMR structure of the complex of Ca2+-CaM with the smMLCK peptide. The N- and
C-lobe wraps around the smMLCK peptide (red helix) (PDB: 2K0F).
We investigated CaM interactions, in its linear and artificial cyclized forms, with its natural
ligand by isothermal titration calorimetry (ITC). We found that the cyclization affects the
enthalpy of calmodulin binding to its ligand, which is compensated by a favorable change in the
entropy of calmodulin binding to its ligand, although the overall binding affinity of interaction
remains the same. Since the conformational entropy of proteins is manifested as the motion
between different structural states, characterization of protein dynamics provides a means to
measure conformational entropy. Thus, we use nuclear magnetic resonance spectroscopy (NMR)
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to compare the backbone dynamics of the CaM constructs in both the linear and circularized
states. We observed a small reduction in the flexibility of CaM, which may contribute to the
lower conformational entropy. The effect of cyclization was more pronounced in the C-lobe with
a slight increase in rigidity of the central loop.

4.2. Experimental Section
Expression and purification
The gene encoding modified CaM was ordered from GenScript, in which the His6-tag, thrombin
cleavage site and a peptide sequence (LCTPSR) were placed at the N-terminus of calmodulin
(residues 2-149, Uniprot P62161). Another similar peptide sequence (LCTPSR) was placed at
the C-terminus just before the stop codon. The gene was inserted into the pET-28b vector
(Novagen) between the NcoI and XhoI restriction sites. The resulting plasmid was -transformed
in the BL21(DE3) cells (Invitrogen). The cells were incubated in LB media with kanamycin with
shaking at 37°C until OD600 = 0.6. The temperature was lowered to 18 °C, and 100 µM IPTG
was added to induce expression of the CaM. The cells were harvested by centrifugation after 1216h. His6-tagged CaM was purified using Ni-agarose resin (Thermo Scientific) in Tris buffer, pH
8, 300mM NaCl. Purifed CaM was then eluted using a concentration gradient of imidazole
(concentration ranging from 5mM to 1M). Eluates were subjected to SDS-PAGE analysis and
fractions containing CaM were pooled and extensively dialyzed using 20mM Tris, pH 8. The
dialyzed sample was further purified using anion exchange chromatography (Resource Q) and
the peak corresponding to CaM was further purified through HiLoad 16/60 Superdex 75 column
(GE Healthcare) equilibrated with 100mM KCl, pH 6.3.
Isothermal Titration Calorimetry (ITC)
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Isothermal titration calorimetry was performed on a low volume Nano ITC, manufactured by TA
instruments, USA. The (smMLCKp) peptide ARRKWQKTGHAVRAIGRLSS, corresponding to
the calmodulin binding region of smooth muscle myosin light chain kinase, was synthesized by
Applied Biosystems, Inc., and further purified by reverse phase HPLC. All experiments were
carried out in 20 mM phosphate buffer, pH 6.3, 100 mM KCl, 6.1 mM CaCl2 at 35°C with a
stirring speed of 200 rpm. Each titration consisted of twenty 2.5 µl injections with 300 s time
intervals. As a control, the heat of dilution was also measured by injecting peptide into buffer
solution containing no CaM. The heat of binding was obtained as the difference between the heat
of reaction and the corresponding heat of dilution. Data analysis was done in NanoAnalyze
Software suite using an “independent” model. In all cases, a stoichiometry of 1 ± 0.1 was
revealed.
Differential scanning calorimetry (DSC)
The purified linear and cyclic CaM at concentrations of 0.3 mM were used for the experiments.
The samples were referenced against the buffer obtained as a filtrate from the concentration step.
Prior to the run, the samples were degassed using vacuum degasser. Thermograms were obtained
by scanning from 10 to 130°C at 1°C/h (scanning rate) at a constant pressure of 3 atm. In total,
three sets of heating, cooling cycles were done using NanoDSC (TA Instruments, USA). The
data was corrected for baseline with a thermogram obtained from the buffer scans.
NMR Spectroscopy
To produce

13

C and

15

N

isotopically labeled CaM, cells were grown in M9 minimal media

containing 13C glucose (2.5g/ltr) and 15NH4Cl (1.1g/ltr) as the sole source of carbon and nitrogen.
NMR samples were prepared as described in Barbato et al [11]. Briefly, a 1mM CaM was
prepared in 95% H2O/5% D2O, 6.1mM CaCl2, and 100mM KCl, pH 6.3. The backbone 1H, 13C,
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and

15

N resonances were assigned based on triple-resonance experiments: HNCA, HNCO,

HNCACB, HN(CO)CA, HN(CA)CO and CBCA(CO)NH, collected using Varian/Agilent
BioPack sequences.
Heteronuclear–15N NOEs, longitudinal (R1), and transverse (R2)

15

N relaxation rates were

measured using standard two-dimensional methods [14]. Steady-state hetero-nuclear 1H-15N
NOE values were determined from spectra recorded with 3s relaxation delay and in the presence
and absence of a proton presaturation period of 4s.

15

N-T1 values were measured from the

spectra recorded with 7 different durations relaxation delays of T= 0.03, 0.08, 0.14, 0.3, 0.5, 0.85
and 1ms. 15N-T2 values were determined from the spectra recorded with 7 different durations of
the delay: T= 0.01, 0.03, 0.05, 0.09, 0.13, 0.170 and 0.25ms. T1, T2 and NOE values were
extracted by a curve-fitting subroutine included in the CCPN software suite[15]. All experiments
were performed at 35°C on 600 MHz magnet (Agilent, USA) equipped with inverse-triple
resonance cold probe. All spectra were processed with NMRPipe [16] and analyzed by CCPN
software suite. The generalized order parameter (S2) was obtained using the FAST-modelfree
program [17].

4.3 Results
4.3.1 CaM Constructs Design and the Evidence of Cyclization
We added a sequence (LCTPSR) at both the N- and C-termini of calmodulin, which appeared to
be sufficient for the formation of disulfide bond between the two cysteines (Cys) to facilitate the
cyclization of the protein (Figure 4.2 a). CaM circularization, via the oxidation of the two
introduced Cys occurred spontaneously during the purification process. Examining the protein by
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) shows that the CaM
existed in a circular form in solution, with the N- and C- termini connected (Lane 5 in Figure 4.2

57

b). The disulfide link is stable against the temperature changes up to 95˚C (Lane 7). The reduced
counterpart is only obtained by adding β-ME with simultaneous heating the protein (Lane 8).
The CaM in its cyclic form (c-CaM) is well separated from the reduced form in the SDS-PAGE
as the result of the changes in its electrophoretic mobility by circularization. The electrophoretic
mobility of the linear CaM (l-CaM), where cysteines have been mutated to alanines, is shown in
lanes 1-4 and resembles that of the reduced c-CaM (Lane 8). The molecular weights of cyclized
and linear CaM were measured using MS and the presence of disulfide linkage within c-CaM
was confirmed by MS/MS. The thermal stability of the calcium saturated linear and circular
CaM were examined by Differential scanning calorimetry (DSC). Though we were able to
estimate the transition temperatures, Tm, complete analysis of the calorimetric data was not
performed owing to the limitations with data fitting at higher temperatures. The transition
temperatures of linear and cyclic CaM were found to be similar, 113˚C and 114˚C respectively
(Figure 4.3), demonstrating high thermal stability for both the constructs. Interestingly, in
addition to the major peak the melting curve of c-CaM, depicts an additional shoulder peak at
95˚C. We speculate that this peak arises from the breakage of the disulfide bond present within
the cyclic CaM and may reflect the separation of N and C domains. However, the overall thermal
stability of CaM is not significantly affected upon cyclization, which is not extraordinary owing
to the resistance of CaM to heat denaturation in calcium-loaded state [18].
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Figure 4.2 (a) Scheme for CaM cyclization showing the additional peptide sequence added to
facilitate disulfide bond formation, and (b) CaM migration patterns on SDS-PAGE gel under
different sample conditions. Control represents Linear CaM where both the Cys are mutated to
alanine.

Figure 4.3 DSC thermograms of linear calmodulin (blue) and cyclic CaM (red)
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4.3.2 Molecular recognition
We used ITC to study the interaction of calcium-saturated linear and cyclic CaM constructs with
its well established ligand, a peptide representing the calmodulin-binding domain of the smooth
muscle myosin light chain kinase (smMLCKp). Figure 4.4 presents binding isotherms at 35°C
for the linear (Figure 4.4 a) and cyclic (Figure 4.4 b) forms of the protein, respectively. Changes
in the Gibbs free energy (ΔG) for the formation of CaM-peptide complex, and the contributions
from enthalpy (ΔH) and entropy (-TΔS) derived from the isotherms are shown in Figure 4.4 c.
Binding of smMLCKp to l-CaM is dominated by a large favorable change in the binding
enthalpy, which compensates the unfavorable change in the binding entropy. Upon cyclization,
the enthalpy term is significantly reduced. However, the associated loss in the overall binding
enthalpy is compensated by the change in the entropy term, converting it from unfavorable to a
favorable factor promoting the interaction. Thus, the overall ΔG of ligand binding remains very
similar between the two constructs (Table 1).

Thermodynamic
Factor

Linear CaM
(kJ/mol)

Cyclic Cam
(kJ/mol)

ΔG

-39.24

-39.46

ΔH

-57.04

-15.06

-TΔS

17.8

-24.4

Table 4.1 Thermodynamic profiles of smMLCK peptide binding to linear and cyclic Calmodulin.
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(a)

(b)

(c)

Figure 4.4 Traces of the calorimetric titration and the binding isotherms obtained for (a) l-CaM
and (b) c-CaM with peptide ligand, smMLCKp, at 35 °C (c) Comparison of the thermodynamic
origins for smMLCKp binding to the l-CaM and c-CaM.
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Binding of calcium-saturated linear and cyclic CaM was also compared using chemical shifts
mapping experiments, through

15

N-HSQC spectra, where non-labeled smMLCK peptide was

titrated into 15N-labeled CaM. This titration was performed at CaM to smMLCKp molar ratios of
1:2 at a pH 6.3. The chemical shift perturbations observed for our modified l-CaM construct
(Figure 4.5) are consistent with CaM binding to smMLCK peptide previously observed [11]. The
effect was similar for c-CaM construct (Figure 4.5), suggesting that the topological constrain did
not impede the formation of a collapsed globular structure of CaM in the presence of smMLCK
peptide.

Linear CaM + smMLCK
Cyclic CaM + smMLCK

Figure 4.5 The superimposition of 15N-HSQC spectra of linear CaM (shown in green) and cyclic
CaM (blue) in the presence of smMLCK at a ratio of 1:2.
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4.3.3 Backbone Dynamics
To assess the backbone dynamics of c-CaM and l-CaM we used
(Figure 4.6). The amide

15

15

N relaxation experiments

N relaxation rates, R1 and R2, and the steady-state heteronuclear

15

N

{1H} NOEs are influenced by the local backbone dynamics on a time scale ranging from
picoseconds to nanoseconds [14]. The order parameter (S2), which describes the amplitude of
fast motions experienced by the individual NH bond vectors, was obtained using Model-free
approach for l-CaM and c-CaM (Figure 4.7 (a) and 4.7(b)[17]. High S2 values, approaching 1,
indicate limited motions and greater rigidity, whereas lower values indicate larger amplitude of
motions and more flexibility [11]. The residues showing spectral overlap in the 15N-HSQC and
those associated with erroneous values in Model-free fitting (error >10%) were omitted from the
relaxation analysis. As shown in Figure 4.7, the S2 values were very similar for the N–terminal
domain and for most of the residues within the C-lobe. Although we expected a greater rigidity
of the central helix, we observed only a slight reduction in the mobility of the central linker
residues upon cyclization. In comparison to the linear CaM, the loops present within the C-lobe
of the cyclized form experience a considerable loss in their flexibility, possibly due to their
proximity to the cyclization site.
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(a)

(b)

(c)
Figure 4.6 (a)-(c) Comparison of the 15N relaxation time, T1, T2, and heteronuclear NOE
measured at 600 MHz for the linear CaM and cyclic CaM.

64

Figure 4.7 Plots of the order parameter (S2) values with respect to residue number of (a) l-CaM
and (b) c-CaM. S2 values are calculated using FAST model free software using R1, R2 and NOE
relaxation data [17].
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4.4 Discussion
The concept of protein cyclization has been increasingly appreciated as cyclic variants exhibit
higher thermal stability and resistance to proteases, thus resulting in an overall better stability of
potential biologicals. Different strategies towards this ultimate goal have adopted from the ones
employed by nature and/or designed de novo. In particular, adding cysteine containing short
peptides to the N- and C-termini have been found successful in circularization of the protein
without affecting its overall fold and biological activities [6]. Similarly, we were able to obtain a
cyclic protein by introducing cysteine-containing sequence (LCTPSR) at the N- and C- termini
of the protein. Since wild type calmodulin does not bear native cysteine residues [19], the
formation of a disulfide bond only occurred between the two cysteines we incorporated at the
extensions of the N- and C-termini. Previous studies by Tan et al, demonstrated the abrogation of
nanomolar (nM) binding affinity of CaM to its ligand, when cysteine mutations were introduced
within the structure of CaM [20]. In contrast, the modified -CaM used in the present study,
maintained its binding profile with the smMLCK peptide, though the dissociation constant (Kd)
is only slightly increased (from few nanomolars to hundreds of nanomolars). Thus, our modified
versions of CaM constructs mimic the native system with minimal perturbations in its threedimensional conformations.
According to the previous calorimetric studies, interactions of CaM with different peptides are
usually driven by a large favorable change in enthalpy [21]. However, in some cases the
enthalpic term is also accompanied by a favorable change in entropy [9]. Thus, the binding
interface of calmodulin is thermodynamically fluid and has been a subject of wide interest and
extensive investigations in the field [10, 21-23]. Our ITC results indicate that the backbone
cyclization of CaM results in an enthalpic-entropic compensation, and, thereby, shifting the
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enthalpy driven process to, largely, the entropy driven interaction. As conformational entropy of
backbone residues can be assessed using the established relationship of NMR-derived order
parameter and entropy [24], we used NMR spectroscopy to study the relaxation properties of the
circularized CaM.
The 15N relaxation data allowed us to calculate S2, the order parameter representing the degree of
flexibility. The S2 values obtained for the residues of linear CaM follow the same trend as the
ones of the wild type (wt) CaM, though the average absolute values are slightly higher due to
increase in the size of our constructs. The l-CaM has S2 value of 0.94 for the N-terminal domain
and 0.89 for the C-terminal domain. However, for the cyclized CaM, the values for N- and Cterminal domains were found to be 0.95 and 0.94, respectively. This is indicative of a reduction
in flexibility of C-terminal domain of calmodulin upon cyclization. Previous studies by Barbato
et al on wt CaM have shown that the N- and the C-domain of CaM behave isotropically while
the residues in the central helix exhibit a high degree of flexibility [11]. Due to the bigger size of
our constructs, the S2 values for l-CaM and C-CaM are on the upper limit, restraining our ability
to calculate conformational entropy using the classical approach.
It appears that C-lobe of l-CaM possesses greater backbone mobility, which is considerably
reduced upon cyclization and may get further reduced upon binding to the smMLCKp. Thus for
c-CaM, the reduced backbone mobility may confer entropic advantages to the ligand binding. On
the other hand, the linear counterpart experiences a strong network of hydrogen bonding (as
indicated by enthalpy change) while at the same time; it has to undergo a tremendous
conformational change to form a compact structure. The total change in entropy also entails the
contribution from side chains as upon binding to smMLCK peptide, the side chains of wt CaM
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has been shown to exhibit a range of motion[25], while the backbone dynamics of wt CaM gets
minimally perturbed.

4.5 Conclusions and future directions
CaM, a calcium modulated protein was modified using a disulfide linkage. A subtle change in
the structure was enough to alter the enthalpy-entropy contributions, however, it was remarkable
to observe that the free energy remain constant. To further qualify these changes, we studied the
backbone dynamics of CaM. Despite the conformational change of the protein, the flexibility of
backbone residues weren’t significantly affected. Previous studies identified that dynamics of
side chains (of wt-CaM) contribute significantly to the binding of smMLCK. It would be useful
to study the dynamics of side chain residues and identify the factors contributing to the enthalpyentropy compensation. Besides, one can also perform H-D exchange experiments in apo and
bound forms to study the effect of solvation that contributes significantly to the entropy term.
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Chapter 5. Conjugation study of engineered cellulase with end
functionalized polymers
The chapter is written in the ‘Methods’ style. A version of Chapter 5 is under preparation for
publication.

5.1 Introduction
The field of chemical biology has recently been surged with designer catalytic machines,
comprising of functionally active enzymes combined with synthetic polymeric scaffolds [1, 2].
The combination, typically called bioconjugates, has been increasingly used in biotechnology
and biomedical research for widespread applications [1, 3-5]. Several methods have been
employed to prepare protein-polymer conjugates, which include direct labeling of free reactive
thiol or amine groups, incorporation of unnatural amino acids, or use of enzyme-based
modifications [6, 7]. Amongst an array of enzyme based protein-polymer conjugation
techniques, a highly selective approach is to fuse the protein of interest to enzymatic
domains/tags that can covalently conjugate with different chemical reporters [1, 5].
The strategy of using enzyme based covalent functionalization of proteins confers many
advantages [7]. It is particularly attractive because the labeling can be controlled at the site of
enzymatic catalysis, resulting in formation of highly specific, efficient and stable covalent
adducts. Being selective and irreversible in nature, the complexes formed, evades the need for
additional purification and do not require subsequent separation steps [8]. Other advantages
include the use of a range of end-functionalized polymers having different scaffolds, and the use
of milder conditions as compared to other chemical reactions. Since direct labeling of target
protein may lead to functional loss, labeling through additional enzymatic tags provides
successful alternate route. The challenge associated with the use of such fusion proteins is to
express the protein of interest without interfering its native activity. Recombinant DNA
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technology, which involves manipulation of DNA at molecular level, alongwith rational design
of the fusion construct have provided effective solutions in expressing engineered proteins that
maintain their functionality [9].
In our current study, we have used two most prevalent enzymes, namely Cutinase, and human
O6-alkylguanine-DNA alkyl transferase (hAGT), referred as SNAP-tag, that can be selfmodified to achieve labeling with differently functionalized polymers [10, 11]. The cutinase-tag
is a 22kDa serine esterase, consisting of Ser-His-Asp catalytic triad [12]. The catalytic serine
residue forms a covalent complex with the phosphonate-functionalized molecules/polymers [13].
On similar lines, SNAP tag, a 21kDa alkyl transferase, can irreversibly react with benzyl-guanine
derivatives. The enzyme transfers the benzyl group from O6-benzylguanine derivatives to its
active cysteine residue to form highly specific covalent adducts [11, 14].
We constructed two different fusion proteins comprising of cutinase tag and SNAP tag
respectively, with our target protein, Cel48F (family 48), an important enzymatic member of
Clostridium cellulolyticum cellulosome [15]. A cellulosome (shown in Figure 5.1) is a multi
enzyme unit comprising of a non-catalytic protein scaffold to which many cellulolytic enzymes
(cellulase) bind to organize into a supramolecular array of protein-enzyme complex [15, 16]. The
cellulolytic enzymes act in concert to catalyze the conversion of cellulose to glucose. This
catalytic conversion is of considerate importance in biofuel industry, as the resultant sugars can
be further fermented into fuel alcohol [17].
Considering the biotechnological significance of the cellulolytic enzymes and inspired by the
hydrolytic efficiency of natural cellulosomes, we are interested in creating artificial cellulosomes
by replacing the protein scaffold with the polymeric scaffold, to which various cellulases can be
conjugated.
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Figure 5.1 A cellulosome assembly. The enzymatic unit consists of a catalytic domain of
cellulase enzyme, a non-catalytic carbohydrate binding module (CBM) and a dockerin unit. The
scaffoldin is a non-catalytic unit comprising of cohesins that bind to Dockerin to form a
cellulosome assembly. Cel48F enzyme used in our studies lacks the CBM. The figure is taken
from Fontes, C.M. et al., Annu Rev Biochem, 2010 [15].
Taken together, we present a method to prepare functionally active Cel48F-cutinase engineered
protein that can be site specifically linked with phosphonate-functionalized polymers (Figure
5.2). In addition, we also present the preliminary results of a differently tagged cellulase, namely,
Cel48F-SNAP that can covalently bind to benzylguanine derivatives (Figure 5.2). By precisely
controlling the number of functional groups on the polymeric scaffold, we can fine-tune the
number of cellulase enzymes being conjugated on to the polymer. The advantages associated
with this approach are its modular nature and the flexibility of decorating the polymeric scaffold
with different functional groups. Here, we have developed a general route to site-specifically link
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enzymes to bi-functionalized polymer scaffolds via bioorthogonal chemistry. Our long-term goal
is to employ a similar strategy to other members of cellulases and prepare supramolecular
assembly that mimics the natural cellulosome.

(a)

(b)

Figure 5.2 (a) Labeling of Cutinase tagged fusion protein with phosphonate derivatives. (b)
Labeling of SNAP tagged fusion protein with benzylguanine derivatives.

5.2 Materials
Equipment: Heating block (Fisher Scientific Isotemp 125D), Incubator (New Brunswick
Scientific), Benchtop mini centrifuge (Fisher Scientific accuSpin MicroR), 1.5 microcentrifuge
tubes, 50ml falcon tubes, French Press, AKTA system (Amersham Biosciences), Magnetic stir
bar, Stirrer, Gel electrophoresis apparatus, Gel imaging system with BioRad GelDoc system,
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Spectrophotometer, nutator mixer (Labnet Rocker 25), Micropipettors, Pipettor tips, dialysis
bags, clips, precast gels, 1ml cuvettes, amicon filters.
Reagents: Kanamycin, agar plates, IPTG, lysozyme, terrific broth Modified EZmix powder
(Sigma), glycerol, Tris base, Tris maleate, sodium chloride, imidazole, calcium chloride, DTT,
2x Laemmli Sample Buffer (Bio-Rad Catalog #1610737), electrophoresis buffer, Avicel (PH101,
Fluka, Buchs, Switzerland). Origami B (DE3) chemically competent cells were purchased from
EMD Biosciences. Ni-NTA agarose was purchased from Qiagen. Complete-Mini EDTA-free
protease inhibitor tablets were purchased from Roche Applied Science.

5.3 Methods
5.3.1 Molecular cloning of fusion proteins
The Cel48F-Cutinase plasmid was constructed from Cel48F plasmid, synthesized by GenScript
Corporation. The restriction site for SalI was introduced by PCR. The resultant product was
ligated with the DNA coding for the cutinase insert (amplified from previously constructed
plasmid). The gene encoding Cel48F-linker-cutinase protein was then cloned into pET26b vector
via NdeI and XhoI, resulting in Cel48F-Cut plasmid. pET26b(Cel48F-SNAP), was generated by
replacing cutinase domain with SNAP domain between HindIII and XhoI. However, the resultant
plasmid had a shorter linker than Cel48F-Cut plasmid.
Transformation of Cel48F plasmids
1.

Set the heating block to a temperature of 42 °C.

2.

Thaw 50ul of E.coli cells (Origami2 (DE3) strain). Add 2ul of plasmid (10-50ng) to 50ul of
cells and incubate in ice bath for 30 minutes.

3.

Heat at 42 °C for 45s, immediately incubate in ice for 2minutes.

4.

Add 400ul of LB and incubate at 37 °C for 45-60 minutes.
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5.

Centrifuge the eppendorf tube for 2minutes.

6.

Discard the media, resuspend in 50ul of media.

7.

Plate the transformation reaction on LB-agar plate supplemented with kanamycin (50ug/ml)
for 16-18 hours at 37 °C.

5.3.2 Expression and purification
Expression:
1.

Pick a single colony from the agar plate, and suspend it in 50ml TB broth having kanamycin
(50ug/ml) antibiotic. Allow it to grow for 12-16 hours at 37 °C with shaking at 225rpm.
This is referred to as seed culture.

2.

Inoculate 1L of autoclaved TB broth with 10mL of seed culture (1:100 dilution). Grow at
37°C with shaking at 225rpm till it reaches O.D=0.6. Transfer the flask to 18°C, and allow it
to cool for an hour. Induce it with 20uM IPTG. Grow at 18°C with shaking at 225rpm for 16
hours.

3.

Harvest cells by centrifuging at 4000rpm for 40minutes. Discard the supernatant and store
the pellet at -20°C, or use it immediately for further purification.

Purification:
1. Preparation of buffers:
Buffer A: 50mM Tris, pH 8.0, 300mM sodium chloride
Buffer B: 50mM Tris, pH 8.0, 300mM sodium chloride, 1M imidazole
Dialysis buffer: 20 mM Tris, pH 8.0
Buffer QA: 20 mM Tris, pH 7.5.
Buffer QB: 20 mM Tris, pH 7.5, 1M NaCl
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2. Preparation of affinity column: Take 2ml Ni-NTA agarose resin (Qiagen #30230) in affinity
column and decant the supernatant. Continue to wash the resin 3 to 5 times with Buffer 1 (table
5.1) to completely remove the ethanol.
Buffer Vol. (ml)

Imidazole (mM) Buffer A (ml) Buffer B (ml)

1

50

5

49.75

0.25

2

50

10

49.5

0.5

3

50

25

48.75

1.25

4

50

40

48

2

5

50

80

46

4

6

50

120

44

6

7

50

160

42

8

8

50

200

40

10

9

50

250

37.5

12.5

10

50

300

35

15

11

50

500

25

25

12

50

1000

0

50

Table 5.1. Preparation of buffers for affinity purification

3. Resuspend the frozen pellet in Buffer A. Add 3mg lysozyme, 1 tablet of EDTA-free protease
inhibitor, 1mM of PMSF. Incubate the cell suspension at room temperature for 20 min.
4. Lyze the cells using French press. Repeat the cell lysis cycle for 4 times. Remove the insoluble
cell debris by centrifugation at 8000rpm for 1 hour at 4 °C.
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5. Load the lysate to the affinity column and incubate with the prepared Ni-NTA agarose resin at
4 °C for 1 hour on a nutator.
6. Wash the resin sequentially with 20 ml of Buffer 1-12 (listed in table 5.1).
7. Check the fractions 1-12 with SDS-PAGE (200V, ~35min).
8. Pool the fractions containing target protein, and dialyse in 1 L of dialysis buffer at 4 °C.
9. Further purify the protein using Resource Q column (GE Healthcare #17-1177-01) on FPLC.
Run a Linear gradient (0-100%B) in 12 CV; 1.5 ml/fraction at a flow rate of 2 ml/min.
10. Check the fractions with SDS-PAGE. (Figure 5.3)
11. Pool the fractions, which contains the desired protein.

Figure 5.3 Gel analysis of purified fractions obtained after anion exchange of Cel48F-Cutinase.
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5.3.3 Conjugation study of Cel48F with bi-functional polymer

Figure 5.4 Scheme of conjugation reaction between modified Cel48F and bifunctional polymer
linker
Optimizing the conjugation conditions

Figure 5.5 SDS-PAGE analysis of Cel48F-cutinase with bifunctional polymer. The samples
were incubated at different ratios for 6, 24, 48 and 72 hours. The dimerization was observed at
pH 6.0, at a temperature of 37°C after 6 hours.
1. Preparation of sample buffer: Add 50ul BME to 950ul of SDS buffer (as per the instructions:
Laemmli Sample Buffer Bio-Rad Catalog #1610737)
2. Incubate 500ul protein (5mM Tris maleate, pH 6, 100mM NaCl) with DODEG polymer at
37°C at different E:L ratio: 1:0 1:1, 1:2, 2:1, 4:1, 1:10, 1:20.
3. Aliquot 50ul of samples after 6, 24, 48 and 72 hours.
4. Prepare 1:1 dilution of sample: sample buffer.
5. Heat the samples at 70°C for 5 minutes.
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6. Load 25ul to the mini-protean gels. Run the gel at 200V for 35minutes.
Dimerization was observed at 1:1, 1:2, 2:1, 4:1 after 6 hours, indicating that the enzyme
conjugated with both the ends of the bi-functional polymer (Figure 5.5). When a higher
concentration of polymer was used, no dimerization was observed (as in the case of 1:10, and
1:20) (data not shown).
Kinetics study for conjugation
1. Prepare 4uM of Cel48F cutinase in 20mM Tris, pH 8, 100mM NaCl.
2. Prepare 0.1M stock solution of DOPEG in DMSO. Dilute the stock solution to 200uM using
the same buffer as above. (At 1:50 ratio, the dimer formation is suppressed).
3. The linker was added just before the UV analysis.
4. Monitor the release of p-nitrophenol of the reaction at 401nm using high throughput UV
spectrophotometer for 15 minutes.
5. The linker was added just before the UV analysis.
6. Monitor the release of p-nitrophenol of the reaction at 401nm using high throughput UV
spectrophotometer for 15 minutes.
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Figure 5.6 Determination of the rate constant for ligand functionalization of Cel48F-Cutinase
EG10 bisphosphonate ligand by monitoring the release of p-nitrophenol at 401 nm. Data were fit
to a pseudo-first order kinetic equation and divided by the concentration of the excess species to
yield effective second order rate constants for the reactions.
The rate constant of the reaction between enzyme and the bisphosphonate linker was obtained by
following the release of p-nitrophenol (λmax = 401nm) with time using UV-Vis absorption
spectroscopy (Figure 5.6). The resulting kinetic trace was fit to a pseudo-first order equation and
the effective second-order rate constant was obtained by dividing these quantities by the
concentration of excess ligand. The observed rate constant was found to be 37.10 M-1s-1.
5.3.4 Cellulase activity assay of the fusion protein
Preparation of solutions:
Solution 1: Potassium ferricyanide solution (0.5g/L)
Solution 2: Carbonate-cyanide solution: (5.3g/L sodium carbonate and 0.65g/L potassium
cyanide)
Solution 3: Ferric ammonium solution: (1.5g/L ferric ammonium sulfate, 2g/L SDS and 0.2N
sulfuric acid)
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Figure 5.7 Mechanism of ferricyanide reducing sugar assay. The intensity of Prussian blue color
is monitored at 690nm.
Protocol for performing ferricyanide reducing sugar assay: The mechanism of the assay [18]
is explained in Figure 5.7.
1. To 300ul of sample, add 100ul of solution 1 and 100ul of solution 2.
2. Heat at 100°C for 15minutes.
3. Cool on ice for 3minutes.
4. Add 500ul of solution 3 to the mix.
5. Wait for 15 minutes. Examine the Prussian blue color formation.
6. Measure absorbance at 690nm (scan between 645-735nm). (Replace sample solution with
buffer to use as your blank).
Cellulase activity assay
1. Perform buffer exchange of Cel48F-cutinase with 20 mM Tris maleate, pH 6.0, 100mM
NaCl, 1 mM CaCl2 using amicon fliter (Mw. Cut off 30kD).
2. Incubate the protein with DODEG polymer at 1:1 ratio.
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Figure 5.8 Avicel hydrolysis by Cel48F-Cutinase in free state (blue trace) or conjugated state
(red trace).
3. Incubate 1uM of protein in free and conjugated state with 4ml of microcrystalline cellulose
(Avicel PH101, Fluka, Buchs, Switzerland) at 20mg/ml in 20 mM Tris maleate, pH 6.0, 1
mM CaCl2.
4. Aliquot 0.6ml at 0, 1, 5 and 24h, centrifuge and transfer the supernatant to a new 1.5ml
eppendorf tube. Examine for soluble reducing sugars using ferricyanide assay.
Figure 5.8 compares the amount of soluble sugars released at different time intervals by the same
amount of proteins, either in the free state or in the conjugated state with bifunctionalized
polymer. The hydrolytic activity of Cel48F is retained upon conjugation and is comparable to
free form.
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Figure 5.9 Avicel hydrolysis by Cel48F-SNAP in free state.
Additionally, we purified Cel48F-SNAP using the same purification protocol. The cellulase
activity of the fusion protein was observed in the free form as depicted in Figure 5.9. While the
polymers for Cel48F-SNAP are currently being synthesized, we tested its ability to conjugate
with commercially available benzylguanine functionalized magnetic beads. We were successful
in our attempt to immobilize the Cel48F-SNAP on magnetic capture beads.

5.4 Conclusions and Future directions
We were able to successfully create differently tagged cellulases that retain the cellulase activity
and can further be conjugated with functionalized polymers. The conjugated enzyme (Cel48FCutinase) has a similar activity as its free form, however we strive to achieve a better activity
profile. This can be observed by attaching cellulases from different families that work
synergistically with Cel48F enzyme. Additionally, HPLC assay would provide quantitative
results in measuring the hydrolytic activity of cellulases. It will also be interesting to develop
brush polymer having multiple chain ends, which can be used to conjugate cellulase. Finally, this
work serves as a foundation to prepare supramolecular assembly of enzymes conjugated to
polymeric scaffolds using different bio-orthogonal chemistry.
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Chapter 6. Conclusions
6.1 Summary and future outlook
Much can be learned about proteins using biophysical and biochemical approaches. Each protein
was investigated from a different perspective. Below, we highlight the conclusions of our studies
on different protein systems, namely integrin-Src, CaM and Cellulase, and offer additional
insights in further exploring these systems.
Extensive studies of both, integrin and Src kinase, have established a critical role of this
interaction in thrombosis and hemostasis as well as in regulation of platelet adhesion. Src kinase
plays an important role in integrin signaling by regulating cytoskeletal organization and cell
remodeling. Previous in vivo studies revealed that SH3 domain of c-Src kinase directly
associates with the C-terminus of β3 integrin cytoplasmic tail. Here, we explored this binding
interface with a combination of different spectroscopic and computational methods. Chemical
shift mapping, PRE, transferred NOE and CD data were used to obtain a docked model of the
complex. This model suggests a different binding mode from the one proposed through previous
studies wherein, the C-terminal end of β3 spans the region in between the RT and n-Src loops of
SH3 domain. Furthermore, we show that tyrosine phosphorylation of β3 prevents this interaction,
supporting the notion of a constitutive interaction between β3 integrin and Src SH3. We, further
investigated the effect of tyrosine phosphorylation of β3, and identified its interaction with Src
SH2. The platelet stimulation studies performed by another group corroborate our results,
supporting the notion that Src can remain bound to activated β3. With identification of this novel
binding mode, a variety of questions still remain unanswered. How integrin mediates Src
activation, what is the role of β3BP in binding to Src SH2, does it displace the pY527 bearing Cterminal tail or are there any conformational changes associated with it? Proposed ITC studies
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can identify the binding affinity and thermodynamic forces driving the interaction between SH2
domain and β3 CT in different phosphorylation states. Based on the Kd values, we can further
provide insights into the mechanism of integrin mediated Src activation. It would also be
interesting to prepare Src SH2 deletion mutants and further study the functional relevance of
these interactions using cell-based assays.
In our second project, we focused our research efforts in understanding the effect of protein
modification on protein’s internal structure and its interaction with its binding partner.
Calmodulin, a calcium modulated protein was modified using a disulfide linkage. A subtle
change in the structure was enough to alter the enthalpy-entropy contributions, however, it was
remarkable to observe that the free energy remain constant. To further qualify these changes, we
studied the backbone dynamics of CaM. Despite the conformational change of the protein, the
flexibility of backbone residues weren’t significantly affected. Previous studies identified that
dynamics of side chains (of wt-CaM) contribute significantly to the binding of smMLCK. It
would be useful to study the dynamics of side chain residues and identify the factors contributing
to the enthalpy-entropy compensation. Besides, one can also perform H-D exchange experiments
in apo and bound forms to study the effect of solvation that contributes significantly to the
entropy term.
Lastly, we investigated engineered proteins and developed its conjugates. Our engineered
proteins and their conjugates maintain their cellulase activity in solution. We strive to achieve
better activity of these enzyme-polymeric conjugates. Additionally, we aim to develop artificial
cellulosome, consisting of a polymeric scaffold, which remains stable at extreme conditions used
in industries. These artificial systems would be prepared by using brush polymers decorated with
different functional groups to which differently tagged proteins can attach.
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Taken together, our studies used multifarious approaches to improve and contribute to the
existing knowledge of proteins involved in cell signaling pathways; addressing the physical
impact of topological constrain on proteins; and developing a general route to site specifically
link proteins to polymeric scaffolds.
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